Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate
- 4 July 2003
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 146 (1) , 62-68
- https://doi.org/10.1016/s0002-8703(03)00118-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Myocardial Dysfunction With Coronary MicroembolizationCirculation Research, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002
- Apoptosis in the Skeletal Muscle of Rats with Heart Failure is Associated with Increased Serum Levels of TNF-α and SphingosineJournal of Molecular and Cellular Cardiology, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Lysophosphatidic Acid and Sphingosine 1-Phosphate: Two Lipid Villains Provoking Cardiovascular Diseases?IUBMB Life, 2000
- Tumor necrosis factor-α, sphingosine, ceramide: Which is the appropriate marker of inflammation?Critical Care Medicine, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- von Willebrand FactorArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging.Heart, 1983